unknown
Stage
2
Investors
About
Arboretum partners with healthcare systems to implement scalable genetic testing programs for cardiovascular, cancer, and metabolic diseases, enabling precision medicine, clinical trials, and translational research.
Explore Arboretum's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.